Skip to primary navigation Skip to main content
0 item $0.00

  1. Abbott A. Best medical intervention for arterial disease or wishful thinking? Eur J Vasc Endovasc Surg 2011;41(4):509-10. Comment.
  2. Abbott A. Letter to the editor: Asymptomatic carotid stenosis-more misunderstandings in the expectation of a surgical benefit. Curr Cardiol Rep 2011;13(4):265-7. Letter.
  3. Abbott AL. Regarding "Asymptomatic carotid artery stenosis - medical therapy alone versus medical therapy plus carotid endarterectomy or stenting". J Vasc Surg 2011;53(1):265. Letter.
  4. Abbott AL. Letter to the editor: asymptomatic carotid stenosis - more misunderstandings in the expectation of a surgical benefit. Curr Cardiol Rep 2011;13(4):265-7; author reply 268. Letter.
  5. Ahimastos AA, Pappas EP, Buttner PG, Walker PJ, Kingwell BA, Golledge J. A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication. J Vasc Surg 2011;54(5):1511-21. Review.
  6. Ahrens I, Domeij H, Eisenhardt SU, Topcic D, Albrecht M, Leitner E, Viitaniemi K, Jowett JB, Lappas M, Bode C, Haviv I, Peter K. Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells. Basic Res Cardiol 2011;106(5):879-95.
  7. Ahrens I, Domeij H, Topcic D, Haviv I, Merivirta RM, Agrotis A, Leitner E, Jowett JB, Bode C, Lappas M, Peter K. Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression. PLoS One 2011;6(8):e23210.
  8. Ahrens I, Habersberger J, Baumlin N, Qian H, Smith BK, Stasch JP, Bode C, Schmidt HH, Peter K. Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free/oxidised Sgc. Atherosclerosis 2011;218(2):431-4.
  9. Ahrens I, Lip GY, Peter K. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation? Thromb Haemost 2011;105(4):574-8. Review.
  10. Al-Fiadh AH, Andrianopoulos N, Farouque O, Yan BP, Duffy SJ, Charter K, Tongyoo S, New G, Yip T, Brennan A, Proimos G, Reid CM, Ajani AE, Clark DJ; on behalf of the Melbourne Interventional Group. Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes. Int J Cardiol 2011;151(2):195-9.
  11. Allen TL, Matthews VB, Febbraio MA. Overcoming insulin resistance with ciliary neurotrophic factor. In: Schwanstecher M (ed), Handbook of Experimental Pharmacology: Diabetes - Perspectives in Drug Therapy, Springer Berlin Heidelberg 2011;203:179-199. Review.
  12. Alssema M, Vistisen D, Heymans MW, Nijpels G, Glümer C, Zimmet PZ, Shaw JE, Eliasson M, Stehouwer CD, Tabák AG, Colagiuri S, Borch-Johnsen K, Dekker JM; DETECT-2 collaboration. Risk scores for predicting type 2 diabetes: using the optimal tool. Diabetologia 2011;54(9):2468-70. Letter.
  13. Alssema M, Vistisen D, Heymans MW, Nijpels G, Glümer C, Zimmet PZ, Shaw JE, Eliasson M, Stehouwer CD, Tabák AG, Colagiuri S, Borch-Johnsen K, Dekker JM; DETECT-2 collaboration. The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia 2011;54(5):1004-12.
  14. Andrianopoulos N, Dinh D, Duffy SJ, Clark DJ, Brennan AL, Chan W, Shardey GC, Smith JA, Yap CH, Buxton BF, Ajani AE, Reid CM. Quality control activities associated with registries in interventional cardiology and surgery. Heart Lung Circ 2011;20(3):180-6.
  15. Anuradha S, Dunstan DW, Healy GN, Shaw JE, Zimmet PZ, Wong TY, Owen N. Physical activity, television viewing time, and retinal vascular caliber. Med Sci Sports Exerc 2011;43(2):280-6.
  16. Anuradha S, Healy GN, Dunstan DW, Klein R, Klein BE, Cotch MF, Wong TY, Owen N. Physical activity, television viewing time, and retinal microvascular caliber: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2011;173(5):518-25.
  17. Anuradha S, Healy GN, Dunstan DW, Tai ES, Van Dam RM, Lee J, Nang EE, Owen N, Wong TY. Associations of physical activity and television viewing time with retinal vascular caliber in a multiethnic Asian population. Invest Ophthalmol Vis Sci 2011;52(9):6522-8.
  18. Astrup A, Dyerberg J, Elwood P, Hermansen K, Hu FB, Jakobsen MU, Kok FJ, Krauss RM, Lecerf JM, LeGrand P, Nestel P, Risérus U, Sanders T, Sinclair A, Stender S, Tholstrup T, Willett WC. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr 2011;93(4):684-8. Review.
  19. Azzi S, Steunou V, Rousseau A, Rossignol S, Thibaud N, Danton F, Le Jule M, Gicquel C, Le Bouc Y, Netchine I. Allele-specific methylated multiplex real-time quantitative PCR (ASMM RTQ-PCR), a powerful method for diagnosing loss of imprinting of the 11p15 region in Russell Silver and Beckwith Wiedemann syndromes. Hum Mutat 2011;32(2):249-58.
  20. Bailie RS, Si D, Connors CM, Kwedza R, O'Donoghue L, Kennedy C, Cox R, Liddle H, Hains J, Dowden MC, Burke HP, Brown A, Weeramanthri T, Thompson S. Variation in quality of preventive care for well adults in Indigenous community health centres in Australia. BMC Health Serv Res 2011;11:139.
  21. Barlovic DP, Soro-Paavonen A, Jandeleit-Dahm KA. RAGE biology, atherosclerosis and diabetes. Clin Sci 2011;121(2):43-55. Review.
  22. Baumert M, Lambert E, Vaddadi G, Sari CI, Esler M, Lambert G, Sanders P, Nalivaiko E. Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt. Clin Neurophysiol 2011;122(2):405-9.
  23. Baumert M, Schlaich MP, Nalivaiko E, Lambert E, Sari CI, Kaye DM, Elser MD, Sanders P, Lambert G. Relation between QT interval variability and cardiac sympathetic activity in hypertension. Am J Physiol Heart Circ Physiol 2011;300(4):H1412-7.
  24. Becker AC, Jacobson B, Singh S, Sliwa K, Stewart S, Libhaber E, Essop MR. The thrombotic profile of treatment-naive HIV-positive Black South Africans with acute coronary syndromes. Clin Appl Thromb-Hemost 2011;17(3):264-72.
  25. Becker AC, Libhaber E, Sliwa K, Singh S, Stewart S, Tikly M, Essop MR. Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates. BMC Res Notes 2011;4:379.
  26. Bennie JA, Timperio AF, Crawford DA, Dunstan DW, Salmon JL. Associations between social ecological factors and self-reported short physical activity breaks during work hours among desk-based employees. Prev Med 2011;53(1-2):44-7.
  27. Berndt NC, O'Riordan DL, Winkler E, McDermott L, Spathonis K, Owen N. Social cognitive correlates of young adult sport competitors' sunscreen use. Health Educ Behav 2011;38(1):6-14.
  28. Berry PA, Wluka AE, Davies-Tuck ML, Wang Y, Strauss BJ, Dixon JB, Proietto J, Jones G, Cicuttini FM. Sex differences in the relationship between bone mineral density and tibial cartilage volume. Rheumatology 2011;50(3):563-8.
  29. Betihavas V, Newton PJ, Du HY, Macdonald PS, Frost SA, Stewart S, Davidson PM. Australia's health care reform agenda: implications for the nurses' role in chronic heart failure management. Aust Crit Care 2011;24(3):189-97. Review.
  30. Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, Watt MJ. Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 2011;60(5):1458-66.
  31. Boslem E, MacIntosh G, Preston AM, Bartley C, Busch AK, Fuller M, Laybutt DR, Meikle PJ, Biden TJ. A lipidomic screen of palmitate-treated MIN6 β-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem J 2011;435(1):267-76.
  32. Boyde M, Turner C, Thompson DR, Stewart S. Educational interventions for patients with heart failure: a systematic review of randomized controlled trials. J Cardiovasc Nurs 2011;26(4):E27-35. Review.
  33. Briggs B, Ververis K, Rodd AL, Foong LJ, Silva FM, Karagiannis TC. Photosensitization by iodinated DNA minor groove binding ligands: Evaluation of DNA double-strand break induction and repair. J Photochem Photobiol B-Biol 2011;103(2):145-52.
  34. Browne JL, Zimmet P, Speight J. Individual responsibility for reducing obesity: the unintended consequences of well intended messages. Med J Aust 2011;195(7):386. Comment.
  35. Buchwald H, Ikramuddin S, Dorman RB, Schone JL, Dixon JB. Management of the metabolic/bariatric surgery patient. Am J Med 2011;124(12):1099-105. Review.
  36. Bullen ML, Miller AA, Andrews KL, Irvine JC, Ritchie RH, Sobey CG, Kemp-Harper BK. Nitroxyl (HNO) as a vasoprotective signaling molecule. Antioxid Redox Signal 2011;14(9):1675-86. Review.
  37. Burch ML, Zheng W, Little PJ. Smad linker region phosphorylation in the regulation of extracellular matrix synthesis. Cell Mol Life Sci 2011;68(1):97-107. Review.
  38. Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on renal excretory function in renovascular hypertension. J Hypertens 2011;29(5):945-52.
  39. Burke SL, Lambert E, Head GA. New approaches to quantifying sympathetic nerve activity. Curr Hypertens Rep 2011;13(3):249-57. Review.
  40. Burns WC, Thomas MC. Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease. Cells Tissues Organs 2011;193(1-2):74-84. Review.
  41. Butler MJ, Chan W, Taylor AJ, Dart AM, Duffy SJ. Management of the no-reflow phenomenon. Pharmacol Ther 2011;132(1):72-85. Review.
  42. Cao Z, Cooper ME. Pathogenesis of diabetic nephropathy. J Diab Invest 2011;2(4):243-7. Review.
  43. Carless MA, Glahn DC, Johnson MP, Curran JE, Bozaoglu K, Dyer TD, Winkler AM, Cole SA, Almasy L, MacCluer JW, Duggirala R, Moses EK, Göring HH, Blangero J. Impact of DISC1 variation on neuroanatomical and neurocognitive phenotypes. Mol Psychiatry 2011;16(11):1096-104.
  44. Carnevali L, Bondarenko E, Sgoifo A, Walker FR, Head GA, Lukoshkova EV, Day TA, Nalivaiko E. Metyrapone and fluoxetine suppress enduring behavioral but not cardiac effects of subchronic stress in rats. Am J Physiol Regul Integr Comp Physiol 2011;301(4):R1123-31.
  45. Chamberlain C, Yore D, Li H, Williams E, Oldenburg B, Oats J, McNamara B, Eades S. Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand, and the United States: a method for systematic review of studies with different designs. BMC Pregnancy Childbirth 2011;11:104.
  46. Chan W, Clark DJ, Ajani AE, Yap CH, Andrianopoulos N, Brennan AL, Dinh DT, Shardey GC, Smith JA, Reid CM, Duffy SJ. Progress towards a National Cardiac Procedure Database--development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) registries. Heart Lung Circ 2011;20(1):10-8. Comment.
  47. Chan W, Dart AM. Vascular stiffness and aging in HIV. Sex Health 2011;8(4):474-84. Review.
  48. Chang L, Kiriazis H, Gao XM, Du XJ, El-Osta A. Cardiac genes show contextual SWI/SNF interactions with distinguishable gene activities. Epigenetics 2011;6(6):760-8.
  49. Chen L, Magliano DJ, Balkau B, Wolfe R, Brown L, Tonkin AM, Zimmet PZ, Shaw JE. Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study. Diabet Med 2011;28(4):414-23.
  50. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2011;8(4):228-36. Review.
  51. Chu PY, Zatta A, Kiriazis H, Chin-Dusting J, Du XJ, Marshall T, Kaye DM. CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess. Circ Heart Fail 2011;4(5):651-8.
  52. Clark BK, Healy GN, Winkler EA, Gardiner PA, Sugiyama T, Dunstan DW, Matthews CE, Owen N. Relationship of television time with accelerometer-derived sedentary time: NHANES. Med Sci Sports Exerc 2011;43(5):822-8.
  53. Clark BK, Thorp AA, Winkler EA, Gardiner PA, Healy GN, Owen N, Dunstan DW. Validity of self-reported measures of workplace sitting time and breaks in sitting time. Med Sci Sports Exerc 2011;43(10):1907-12.
  54. Clifton P. High-protein and low-glycaemic diets improve dietary compliance and maintenance of weight loss in overweight adults who have lost weight on a low-calorie diet. Evid Based Med 2011;16(4):112-3. Review.
  55. Clifton P. Protein and coronary heart disease: the role of different protein sources. Curr Atheroscler Rep 2011;13(6):493-8. Review.
  56. Clifton P. Low-carbohydrate diets for weight loss: the pros and cons. J Hum Nutr Diet 2011;24(6):523-4. Comment.
  57. Clifton P. Palm oil and LDL cholesterol. Am J Clin Nutr 2011;94(6):1392-3. Comment.
  58. Clifton P. Comment on Ramsden et al. Br J Nutr 2011;106(6):958;author reply 959-60. Comment.
  59. Clifton PM. Bariatric surgery: results in obesity and effects on metabolic parameters. Curr Opin Lipidol 2011;22(1):1-5. Review.
  60. Clifton PM. Nutrition and metabolism. Curr Opin Lipidol 2011;22(2):142-3. Review.
  61. Clifton PM, Chan L, Moss CL, Miller MD, Cobiac L. Beverage intake and obesity in Australian children. Nutr Metab 2011;8(1):87.
  62. Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K; DETECT-2 Collaboration Writing Group. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2011;34(1):145-50.
  63. Coughlan MT, Forbes JM. Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes. Am J Nephrol 2011;34(1):9-17.
  64. Coughlan MT, Patel SK, Jerums G, Penfold SA, Nguyen TV, Sourris KC, Panagiotopoulos S, Srivastava PM, Cooper ME, Burrell LM, Macisaac RJ, Forbes JM. Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man. Am J Nephrol 2011;34(4):347-55.
  65. Coughlan MT, Yap FY, Tong DC, Andrikopoulos S, Gasser A, Thallas-Bonke V, Webster DE, Miyazaki J, Kay TW, Slattery RM, Kaye DM, Drew BG, Kingwell BA, Fourlanos S, Groop PH, Harrison LC, Knip M, Forbes JM. Advanced glycation end products are direct modulators of β-cell function. Diabetes 2011;60(10):2523-32.
  66. Csizmadi I, Lo Siou G, Friedenreich CM, Owen N, Robson PJ. Hours spent and energy expended in physical activity domains: results from the Tomorrow Project cohort in Alberta, Canada. Int J Behav Nutr Phys Act 2011;8:110.
  67. Cullen-McEwen LA, Armitage JA, Nyengaard JR, Moritz KM, Bertram JF. A design-based method for estimating glomerular number in the developing kidney. Am J Physiol Renal Physiol 2011;300(6):F1448-53.
  68. Curran JE, Meikle PJ, Blangero J. New approaches for the discovery of lipid-related genes. Clin Lipidol 2011;6(5):495-500. Review.
  69. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Magliano D; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378(9785):31-40.
  70. Daniel M, Lekkas P, Cargo M, Stankov I, Brown A. Environmental risk conditions and pathways to cardiometabolic diseases in indigenous populations. Annu Rev Public Health 2011;32:327-47. Review.
  71. Davern PJ, Head GA. Role of the medial amygdala in mediating responses to aversive stimuli leading to hypertension. Clin Exp Pharmacol Physiol 2011;38(2):136-43. Review.
  72. Dawson AP, Schluter PJ, Hodges PW, Stewart S, Turner C. Fear of movement, passive coping, manual handling, and severe or radiating pain increase the likelihood of sick leave due to low back pain. Pain 2011;152(7):1517-24.
  73. de Haan JB. Nrf2 activators as attractive therapeutics for diabetic nephropathy. Diabetes 2011;60(11):2683-4. Comment.
  74. de Haan JB, Cooper ME. Targeted antioxidant therapies in hyperglycemia-mediated endothelial dysfunction. Front Biosci (Schol Ed) 2011;3:709-29. Review.
  75. Demars J, Le Bouc Y, El-Osta A, Gicquel C. Epigenetic and genetic mechanisms of abnormal 11p15 genomic imprinting in Silver-Russell and Beckwith-Wiedemann syndromes. Curr Med Chem 2011;18(12):1740-50.
  76. Demars J, Rossignol S, Netchine I, Syin Lee K, Shmela M, Faivre L, Weill J, Odent S, Azzi S, Callier P, Lucas J, Dubourg C, Andrieux J, Le Bouc Y, El-Osta A, Gicquel C. New insights into the pathogenesis of Beckwith-Wiedemann and Silver-Russell syndromes: Contribution of small copy number variations to 11p15 imprinting defects. Hum Mutat 2011;32(10):1171-82.
  77. Desmond MJ, Lee D, Fraser SA, Katerelos M, Gleich K, Martinello P, Li YQ, Thomas MC, Michelucci R, Cole AJ, Saftig P, Schwake M, Stapleton D, Berkovic SF, Power DA. Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2/Limp-2. Am J Physiol Renal Physiol 2011;300(6):F1437-47.
  78. Dickinson KM, Clifton PM, Keogh JB. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr 2011;93(3):500-5.
  79. Ding D, Sallis JF, Hovell MF, Du J, Zheng M, He H, Owen N. Physical activity and sedentary behaviours among rural adults in Suixi, China: a cross-sectional study. Int J Behav Nutr Phys Act 2011;8:37.
  80. Dixon AF, le Roux CW, Ghatei MA, Bloom SR, McGee TL, Dixon JB. Pancreatic polypeptide meal response may predict gastric band-induced weight loss. Obes Surg 2011;21(12):1906-13.
  81. Dixon JB, Dixon ME. Pregnancy May Increase the Risk of Proximal Gastric Pouch Dilatation after LAGB Surgery. Obes Surg 2011;21(10):1640-1. Comment.
  82. Dixon JB, Fitzgerald DA, Kow L, Bailey D, Baur LA. Adolescent bariatric surgery: ANZ guidance and recommendations. ANZ J Surg 2011;81(12):854-5. Review.
  83. Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol 2011;8(8):429-37. Review.
  84. Dixon JB, Zimmet P, Alberti KG, Mbanya JC, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery for diabetes: the International Diabetes Federation takes a position. J Diabetes 2011;3(4):261-4. Statement.
  85. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Arq Bras Endocrinol Metabol 2011;55(6):367-82. Statement.
  86. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Surg Obes Relat Dis 2011;7(4):433-47. Statement.
  87. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011;28(6):628-42. Statement.
  88. DREAM On (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Ongoing Follow-up) Investigators, Gerstein HC, Mohan V, Avezum A, Bergenstal RM, Chiasson JL, Garrido M, MacKinnon I, Rao PV, Zinman B, Jung H, Joldersma L, Bosch J, Yusuf S. Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes. Diabetologia 2011;54(3):487-95.
  89. Drew BG, Carey AL, Natoli AK, Formosa MF, Vizi D, Reddy-Luthmoodoo M, Weir JM, Barlow CK, van Hall G, Meikle PJ, Duffy SJ, Kingwell BA. Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus. J Lipid Res 2011;52(3):572-81.
  90. Driscoll A, Tonkin A, Stewart A, Thompson DR, Worrall-Carter L, Riegel B, Hare DL, Davidson PM, Stewart S. Development of an evidence-based scoring system (HF-IS) to assess the quality of heart failure programmes for patients postdischarge from hospital. J Clin Nurs 2011;20(21-22):3011-9.
  91. Driscoll A, Worrall-Carter L, Hare DL, Davidson PM, Riegel B, Tonkin A, Stewart S. Evidence-based chronic heart-failure management programmes: reality or myth? BMJ Qual Saf 2011;20(1):31-7.
  92. Du XJ, Kiriazis H, Dart AM. Arterial remodeling following pressure overload by aortic constriction: an overlooked and potentially fertile research area. Clin Exp Pharmacol Physiol 2011;38(9):559-61. Editorial.
  93. Du XJ, Shan L, Gao XM, Kiriazis H, Liu Y, Lobo A, Head GA, Dart AM. Role of intramural platelet thrombus in the pathogenesis of wall rupture and intra-ventricular thrombosis following acute myocardial infarction. Thromb Haemost 2011;105(2):356-64.
  94. Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation 2011;123(1):46-52.
  95. Duerschmied D, Meiner M, Peter K, Neudorfer I, Roming F, Zirlik A, Bode C, von Elverfeldt D, von Zur Muhlen C. Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis. Invest Radiol 2011;46(10):618-23.
  96. Dunstan D. Diabetes: exercise and T2DM-move muscles more often!. Nat Rev Endocrinol 2011;7(4):189-90. Letter.
  97. Dunstan DW, Thorp AA, Healy GN. Prolonged sitting: is it a distinct coronary heart disease risk factor? Curr Opin Cardiol 2011;26(5):412-9. Review.
  98. Dupic L, Huet O, Duranteau J. Coenzyme Q10 deficiency in septic shock patients. Crit Care 2011;15(5):194. Editorial.
  99. Dwyer T, Ponsonby AL, Ukoumunne OC, Pezic A, Venn A, Dunstan D, Barr E, Blair S, Cochrane J, Zimmet P, Shaw J. Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study. Br Med J 2011;342:c7249.
  100. Egger G, Dixon J. Non-nutrient causes of low-grade, systemic inflammation: support for a 'canary in the mineshaft' view of obesity in chronic disease. Obes Rev 2011;12(5):339-45. Review.
  101. Eikelis N, Hennebry SC, Lambert GW, Schlaich MP. Does renalase degrade catecholamines? Kidney Int 2011;79(12):1380. Letter.
  102. Eisenhardt SU, Habersberger J, Oliva K, Lancaster GI, Ayhan M, Woollard KJ, Bannasch H, Rice GE, Peter K. A proteomic analysis of C-reactive protein stimulated THP-1 monocytes. Proteome Sci 2011;9(1):1.
  103. Ekinci EI, Clarke S, Thomas MC, Moran JL, Cheong K, MacIsaac RJ, Jerums G. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011;34(3):703-9.
  104. Elliott DA, Braam SR, Koutsis K, Ng ES, Jenny R, Lagerqvist EL, Biben C, Hatzistavrou T, Hirst CE, Yu QC, Skelton RJ, Ward-van Oostwaard D, Lim SM, Khammy O, Li X, Hawes SM, Davis RP, Goulburn AL, Passier R, Prall OW, Haynes JM, Pouton CW, Kaye DM, Mummery CL, Elefanty AG, Stanley EG. NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods 2011;8(12):1037-40.
  105. El-Osta A. Remodeling is at the heart of chromatin: the heartaches of chromatin. Epigenetics 2011;6(7):884-7. Comment.
  106. Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, Sarwar N, Kizer JR, Lawlor DA, Nordestgaard BG, Ridker P, Salomaa V, Stevens J, Woodward M, Sattar N, Collins R, Thompson SG, Whitlock G, Danesh J. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011;377(9771):1085-95.
  107. Esler M. The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp Physiol 2011;96(7):611-22. Editorial.
  108. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM, Lin JK, Stevens GA, Riley LM, Magliano D; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol). National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3•0 million participants. Lancet 2011;377(9765):578-86.
  109. Feldman A, Voskoboinik A, Kumar S, Spence S, Morton JB, Kistler PM, Sparks PB, Vohra JK, Kalman JM. Predictors of acute and long-term success of slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center series of 1,419 consecutive patients. Pacing Clin Electrophysiol 2011;34(8):927-33.
  110. Fernando H, Bassler N, Habersberger J, Sheffield LJ, Sharma R, Dart AM, Peter KH, Shaw JA. Randomized double-blind placebo-controlled crossover study to determine the effects of esomeprazole on inhibition of platelet function by clopidogrel. J Thromb Haemost 2011;9(8):1582-9.
  111. Fernando H, Dart AM, Peter K, Shaw JA. Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy. Thromb Haemost 2011;105(6):933-44. Review.
  112. Forbes JM, Söderlund J, Yap FY, Knip M, Andrikopoulos S, Ilonen J, Simell O, Veijola R, Sourris KC, Coughlan MT, Forsblom C, Slattery R, Grey ST, Wessman M, Yamamoto H, Bierhaus A, Cooper ME, Groop PH. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia 2011;54(5):1032-42.
  113. Forsblom C, Harjutsalo V, Thorn LM, Wadén J, Tolonen N, Saraheimo M, Gordin D, Moran JL, Thomas MC, Groop PH; FinnDiane Study Group. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2011;22(3):537-44.
  114. Forsblom C, Thomas MC, Moran J, Saraheimo M, Thorn L, Wadén J, Gordin D, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane Study Group. Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med 2011;270(4):346-55.
  115. Fröjdö S, Durand C, Molin L, Carey AL, El-Osta A, Kingwell BA, Febbraio MA, Solari F, Vidal H, Pirola L. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 2011;335(2):166-76.
  116. Fuller M, Tucker JN, Lang DL, Dean CJ, Fietz MJ, Meikle PJ, Hopwood JJ. Screening patients referred to a metabolic clinic for lysosomal storage disorders. J Med Genet 2011;48(6):422-5.
  117. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Grantham N, Ebeling PR, Daly RM. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 2011;34(5):1133-8.
  118. Gao XM, Liu Y, White D, Su Y, Drew BG, Bruce CR, Kiriazis H, Xu Q, Jennings N, Bobik A, Febbraio MA, Kingwell BA, Bucala R, Fingerle-Rowson G, Dart AM, Morand EF, Du XJ. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol 2011;50(6):991-9.
  119. Gardiner PA, Clark BK, Healy GN, Eakin EG, Winkler EA, Owen N. Measuring older adults' sedentary time: reliability, validity, and responsiveness. Med Sci Sports Exerc 2011;43(11):2127-33.
  120. Gardiner PA, Eakin EG, Healy GN, Owen N. Feasibility of reducing older adults' sedentary time. Am J Prev Med 2011;41(2):174-7.
  121. Gardiner PA, Healy GN, Eakin EG, Clark BK, Dunstan DW, Shaw JE, Zimmet PZ, Owen N. Associations between television viewing time and overall sitting time with the metabolic syndrome in older men and women: the Australian Diabetes, Obesity and Lifestyle study. J Am Geriatr Soc 2011;59(5):788-96.
  122. Gebel K, Bauman AE, Sugiyama T, Owen N. Mismatch between perceived and objectively assessed neighborhood walkability attributes: prospective relationships with walking and weight gain. Health Place 2011;17(2):519-24.
  123. Gluckman PD, Hanson M, Zimmet P, Forrester T. Losing the war against obesity: the need for a developmental perspective. Sci Transl Med 2011;3(93):93cm19. Editorial.
  124. Gollan PJ, Ziemann M, Bhave M. PPIase activities and interaction partners of FK506-binding proteins in the wheat thylakoid. Physiol Plant 2011;143(4):385-95.
  125. Gombos I, Crul T, Piotto S, Güngör B, Török Z, Balogh G, Péter M, Slotte JP, Campana F, Pilbat AM, Hunya A, Tóth N, Literati-Nagy Z, Vígh L Jr, Glatz A, Brameshuber M, Schütz GJ, Hevener A, Febbraio MA, Horváth I, Vígh L. Membrane-lipid therapy in operation: the HSP co-inducer BGP-15 activates stress signal transduction pathways by remodeling plasma membrane rafts. PLoS One 2011;6(12):e28818.
  126. Goode AD, Winkler EA, Lawler SP, Reeves MM, Owen N, Eakin EG. A telephone-delivered physical activity and dietary intervention for type 2 diabetes and hypertension: does intervention dose influence outcomes? Am J Health Promot 2011;25(4):257-63.
  127. Gray SP, Cooper ME. Diabetic nephropathy in 2010: alleviating the burden of diabetic nephropathy. Nat Rev Nephrol 2011;7(2):71-3. Review.
  128. Grubb DR, Iliades P, Cooley N, Yu YL, Luo J, Filtz TM, Woodcock EA. Phospholipase C{beta}1b associates with a Shank3 complex at the cardiac sarcolemma. FASEB J 2011;25(3):1040-7.
  129. Hansen J, Brandt C, Nielsen AR, Hojman P, Whitham M, Febbraio MA, Pedersen BK, Plomgaard P. Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine. Endocrinology 2011;152(1):164-71.
  130. Harcourt BE, Sourris KC, Coughlan MT, Walker KZ, Dougherty SL, Andrikopoulos S, Morley AL, Thallas-Bonke V, Chand V, Penfold SA, de Courten MP, Thomas MC, Kingwell BA, Bierhaus A, Cooper ME, Courten B, Forbes JM. Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int 2011;80(2):190-8.
  131. Hawkes AL, Lynch BM, Owen N, Aitken JF. Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. Eur J Cancer 2011;47(2):267-76.
  132. Hayden MJ, Dixon JB, Dixon ME, Shea TL, O'Brien PE. Characterization of the improvement in depressive symptoms following bariatric surgery. Obes Surg 2011;21(3):328-35.
  133. He Z, Vingrys AJ, Armitage JA, Bui BV. The role of blood pressure in glaucoma. Clin Exp Optom 2011;94(2):133-49. Review.
  134. Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M, Mangoni AA, Cowley D, Wilson A; National Heart Foundation and High Blood Pressure Research Council of Australia Ambulatory Blood Pressure Monitoring Consensus Committee. Ambulatory blood pressure monitoring. Aust Fam Physician 2011;40(11):877-80.
  135. Healy GN, Matthews CE, Dunstan DW, Winkler EA, Owen N. Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. Eur Heart J 2011;32(5):590-7.
  136. Heck PM, Rosso R, Kistler PM. The challenging face of focal atrial tachycardia in the post AF ablation era. J Cardiovasc Electrophysiol 2011;22(7):832-8. Review.
  137. Heidt T, Deininger F, Peter K, Goldschmidt J, Pethe A, Hagemeyer CE, Neudorfer I, Zirlik A, Weber WA, Bode C, Meyer PT, Behe M, von Zur Mühlen C. Activated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibody. PLoS One 2011;6(3):e18446.
  138. Hering D, Esler MD, Krum H, Mahfoud F, Böhm M, Sobotka PA, Schlaich MP. Recent advances in the treatment of hypertension. Expert Rev Cardiovasc Ther 2011;9(6):729-44. Review.
  139. Herman-Edelstein M, Thomas MC, Thallas-Bonke V, Saleem M, Cooper ME, Kantharidis P. Dedifferentiation of immortalized human podocytes in response to transforming growth factor-{beta}: a model for diabetic podocytopathy. Diabetes 2011;60(6):1779-88.
  140. Holman RR, Zinman B, Yusuf S, Sheridan PM, Anand SS, Bosch JJ, Conget I, Davies MJ, Pirags V, Dagenais GR, Pogue JM, Zimmet PZ, Gerstein HC; DREAM Trial Investigators. Incidence of diabetes following ramipril or rosiglitazone withdrawal. Diabetes Care 2011;34(6):1265-9.
  141. Holtkamp FA, de Zeeuw D, Thomas MC, Cooper ME, de Graeff PA, Hillege HJ, Parving HH, Brenner BM, Shahinfar S, Lambers Heerspink HJ. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int 2011;80(3):282-7.
  142. Hossain MA, Man BC, Zhao C, Xu Q, Du XJ, Wade JD, Samuel CS. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor. Biochemistry 2011;50(8):1368-75.
  143. Hoy AJ, Bruce CR, Turpin SM, Morris AJ, Febbraio MA, Watt MJ. Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation. Endocrinology 2011;152(1):48-58.
  144. Hu H, Armstrong PC, Khalil E, Chen YC, Straub A, Li M, Soosairajah J, Hagemeyer CE, Bassler N, Huang D, Ahrens I, Krippner G, Gardiner E, Peter K. GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLoS One 2011;6(4):e19190.
  145. Huet O, Dupic L, Batteux F, Matar C, Conti M, Chereau C, Lemiale V, Harrois A, Mira JP, Vicaut E, Cariou A, Duranteau J. Postresuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage. Crit Care Med 2011;39(7):1712-20.
  146. Huet O, Dupic L, Harrois A, Duranteau J. Oxidative stress and endothelial dysfunction during sepsis. Front Biosci 2011;16:1986-95. Review.
  147. Huxley RR, Barzi F, Lam TH, Czernichow S, Fang X, Welborn T, Shaw J, Ueshima H, Zimmet P, Jee SH, Patel JV, Caterson I, Perkovic V, Woodward M; Asia Pacific Cohort Studies Collaboration and the Obesity in Asia Collaboration. Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific region. Circulation 2011;124(19):5056-64.
  148. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 2011;57(7):821-8.
  149. Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JG. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail 2011;13(9):1028-70. Review.
  150. Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JG. Telemedicine and remote management of heart failure. Lancet 2011;378(9806):e9; author reply e10. Author reply.
  151. Irvine J, Kemp-Harper BK, Widdop RE. Chronic administration of the HNO donor, Angeli's salt does not lead to tolerance, cross-tolerance or endothelial dysfunction: comparison with GTN and DEA/NO. Antioxid Redox Signal 2011;14(9):1615-24.
  152. Jennings GL, Macmahon S, Donnan GA. Cuts to the NHMRC budget will undermine the health of all Australians - today and in the future. Med J Aust 2011;194(9):436-7. Editorial.
  153. Jesudason D, Clifton P. The interaction between dietary protein and bone health. J Bone Miner Metab 2011;29(1):1-14. Review.
  154. Jones KM, Dixon ME, Falkingham L, Piteman L, Dixon JB. Barriers to recruitment of professionals into a general practice childhood obesity program. Aust J Prim Health 2011;17(2):156-61.
  155. Jordan J, Schlaich M, Redon J, Narkiewicz K, Luft FC, Grassi G, Dixon J, Lambert G, Engeli S; European Society of Hypertension Working Group on Obesity; Australian and New Zealand Obesity Society. European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes. J Hypertens 2011;29(2):189-93. Review.
  156. Ju YK, Liu J, Lee BH, Lai D, Woodcock EA, Lei M, Cannell MB, Allen DG. Distribution and functional role of inositol 1,4,5-trisphosphate receptors in mouse sinoatrial node. Circ Res 2011;109(8):848-57.
  157. Kalff V, Duffy SJ, Taylor AJ. A new algorithm for the management of stable coronary artery disease incorporating CT coronary angiography and fractional flow reserve: how we can improve outcomes and reduce costs. Med J Aust 2011;194(12):666-7. Letter.
  158. Kanellakis P, Agrotis A, Kyaw TS, Koulis C, Ahrens I, Mori S, Takahashi HK, Liu K, Peter K, Nishibori M, Bobik A. High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 2011;31(2):313-9.
  159. Kanellakis P, Dinh TN, Agrotis A, Bobik A. CD4⁺CD25⁺Foxp3⁺ regulatory T cells suppress cardiac fibrosis in the hypertensive heart. J Hypertens 2011;29(9):1820-8.
  160. Kantharidis P, Wang B, Carew RM, Lan HY. Diabetes complications: the microRNA perspective. Diabetes 2011;60(7):1832-7. Review.
  161. Karagiannis MJ, Chivers L, Karagiannis TC. Effects of oral intake of water in patients with oropharyngeal dysphagia. BMC Geriatr 2011;11:9.
  162. Keogh JB, Wooster TJ, Golding M, Day L, Otto B, Clifton PM. Slowly and rapidly digested fat emulsions are equally satiating but their triglycerides are differentially absorbed and metabolized in humans. J Nutr 2011;141(5):809-15.
  163. Komers R, Oyama TT, Beard DR, Tikellis C, Xu B, Lotspeich DF, Anderson S. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Kidney Int 2011;79(4):432-42.
  164. Konstantopoulos N, Foletta VC, Segal DH, Shields KA, Sanigorski A, Windmill K, Swinton C, Connor T, Wanyonyi S, Dyer TD, Fahey RP, Watt RA, Curran JE, Molero JC, Krippner G, Collier GR, James DE, Blangero J, Jowett JB, Walder KR. A gene expression signature for insulin resistance. Physiol Genomics 2011;43(3):110-20.
  165. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P, Been LF, Chia KS, Dimas AS, Hassanali N, Jafar T, Jowett JB, Li X, Radha V, Rees SD, Takeuchi F, Young R, Aung T, Basit A, Chidambaram M, Das D, Grundberg E, Hedman AK, Hydrie ZI, Islam M, Khor CC, Kowlessur S, Kristensen MM, Liju S, Lim WY, Matthews DR, Liu J, Morris AP, Nica AC, Pinidiyapathirage JM, Prokopenko I, Rasheed A, Samuel M, Shah N, Shera AS, Small KS, Suo C, Wickremasinghe AR, Wong TY, Yang M, Zhang F; DIAGRAM; MuTHER, Abecasis GR, Barnett AH, Caulfield M, Deloukas P, Frayling TM, Froguel P, Kato N, Katulanda P, Kelly MA, Liang J, Mohan V, Sanghera DK, Scott J, Seielstad M, Zimmet PZ, Elliott P, Teo YY, McCarthy MI, Danesh J, Tai ES, Chambers JC. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 2011;43(10):984-9.
  166. Kowalski GM, Nicholls HT, Risis S, Watson NK, Kanellakis P, Bruce CR, Bobik A, Lancaster GI, Febbraio MA. Deficiency of haematopoietic-cell-derived IL-10 does not exacerbate high-fat-diet-induced inflammation or insulin resistance in mice. Diabetologia 2011;54(4):888-99.
  167. Krautwald M, Leech D, Horne S, Steele ML, Forbes J, Rahmadi A, Griffith R, Münch G. The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase. Rejuv Res 2011;14(4):383-91.
  168. Krum H, Jelinek MV, Stewart S, Sindone A, Atherton JJ; National Heart Foundation of Australia; Cardiac Society of Australia and New Zealand. 2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Med J Aust 2011;194(8):405-9. Guidelines.
  169. Krum H, Schlaich M, Sobotka P, Scheffers I, Kroon AA, de Leeuw PW. Novel procedure- and device-based strategies in the management of systemic hypertension. Eur Heart J 2011;32(5):537-44. Review.
  170. Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 2011;123(2):209-15. Review.
  171. Kwa FA, Balcerczyk A, Licciardi P, El-Osta A, Karagiannis TC. Chromatin modifying agents - the cutting edge of anticancer therapy. Drug Discov Today 2011;16(13-14):543-7. Review.
  172. Kyaw T, Tay C, Dumouchel V, Cao A, Tipping P, Bobik A, Toh BH. Response to Comment on "Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis". J Immunol 2011;186(1):4-5. Author reply.
  173. Kyaw T, Tay C, Krishnamurthi S, Kanellakis P, Agrotis A, Tipping P, Bobik A, Toh BH. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 2011;109(8):830-40.
  174. Kyaw T, Tipping P, Toh BH, Bobik A. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis. Curr Opin Lipidol 2011;22(5):373-9.
  175. La Gerche A, Heidbüchel H, Burns AT, Mooney DJ, Taylor AJ, Pfluger HB, Inder WJ, Macisaac AI, Prior DL. Disproportionate exercise load and remodeling of the athlete's right ventricle. Med Sci Sports Exerc 2011;43(6):974-81.
  176. Lainscak M, Blue L, Clark AL, Dahlström U, Dickstein K, Ekman I, McDonagh T, McMurray JJ, Ryder M, Stewart S, Strömberg A, Jaarsma T. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2011;13(2):115-26.
  177. Laker RC, Gallo LA, Wlodek ME, Siebel AL, Wadley GD, McConell GK. Short-term exercise training early in life restores deficits in pancreatic β-cell mass associated with growth restriction in adult male rats. Am J Physiol Endocrinol Metab 2011;301(5):E391-40.
  178. Lakerveld J, Dunstan D, Bot S, Salmon J, Dekker J, Nijpels G, Owen N. Abdominal obesity, TV-viewing time and prospective declines in physical activity. Prev Med 2011;53(4-5):299-302.
  179. Lam YY, Hatzinikolas G, Weir JM, Janovská A, McAinch AJ, Game P, Meikle PJ, Wittert GA. Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the effects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochim Biophys Acta-Mol Cell Lipids 2011;1811(7-8):468-75.
  180. Lambert E, Lambert G, Ika-Sari C, Dawood T, Lee K, Chopra R, Straznicky N, Eikelis N, Drew S, Tilbrook A, Dixon J, Esler M, Schlaich MP. Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension 2011;58(1):43-50.
  181. Lambert E, Straznicky NE, Dawood T, Ika-Sari C, Grima M, Esler MD, Schlaich MP, Lambert GW. Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome. Front Physiol 2011;5:52.
  182. Lambert EA, Lambert GW. Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome. Curr Hypertens Rep 2011;13(3):244-8. Review.
  183. Lambert EA, Schlaich MP, Dawood T, Sari C, Chopra R, Barton DA, Kaye DM, Elam M, Esler MD, Lambert GW. Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover. J Physiol 2011;589(Pt 10):2597-605.
  184. Lancaster GI, Febbraio MA. Adiponectin sphings into action. Nat Med 2011;17(1):37-8. Comment.
  185. Larsen RN, Mann NJ, Maclean E, Shaw JE. The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial. Diabetologia 2011;54(4):731-40.
  186. Lee G, Kalman JM, Vohra JK, Teh A, Medi C, Ling LH, Kistler PM. Dissociated pulmonary vein potentials following antral pulmonary vein isolation for atrial fibrillation: impact on long-term outcome. Heart 2011;97(7):579-84.
  187. Lee G, Roberts-Thomson K, Madry A, Spence S, Teh A, Heck PM, Kumar S, Kistler PM, Morton JB, Sanders P, Kalman JM. Relationship among complex signals, short cycle length activity, and dominant frequency in patients with long-lasting persistent AF: a high-density epicardial mapping study in humans. Heart Rhythm 2011;8(11):1714-9.
  188. Lee G, Sparks PB, Morton JB, Kistler PM, Vohra JK, Medi C, Rosso R, Teh A, Halloran K, Kalman JM. Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J Cardiovasc Electrophysiol 2011;22(2):163-8.
  189. Lim K, Armitage JA, Stefanidis A, Oldfield BJ, Jane Black M. IUGR in the absence of postnatal "catch-up" growth leads to improved whole body insulin sensitivity in rat offspring. Pediatr Res 2011;70(4):339-44.
  190. Ling LH, Kistler PM. Multielectrode catheter ablation: linear ablation made easy? J Cardiovasc Electrophysiol 2011;22(7):746-7. Editorial.
  191. Lithovius R, Harjutsalo V, Forsblom C, Groop PH; on behalf of the FinnDiane Study Group. Cumulative cost of prescription medication in outpatients with Type 1 diabetes in Finland. Diabetologia 2011;54(3):496-503.
  192. Little PJ, Chait A, Bobik A. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Pharmacol Ther 2011;131(3):255-68. Review.
  193. Liu Y, Gao XM, Fang L, Jennings NL, Su Y, Xu Q, Samson AL, Kiriazis H, Wang XF, Shan L, Sturgeon SA, Medcalf RL, Jackson SP, Dart AM, Du XJ. Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction. Arterioscler Thromb Vasc Biol 2011;31(4):834-41.
  194. Lobachevsky PN, Vasireddy RS, Broadhurst S, Sprung CN, Karagiannis TC, Smith AJ, Radford IR, McKay MJ, Martin RF. Protection by methylproamine of irradiated human keratinocytes correlates with reduction of DNA damage. Int J Radiat Biol 2011;87(3):274-83.
  195. Lu KJ, Yan BP, Ajani AE, Wilson WM, Duffy SJ, Gurvitch R, Clark DJ, Brennan A, Reid C, Andrianopoulos N, Krum H; Melbourne Interventional Group. Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: analysis of the Melbourne Interventional Group registry. Eur J Heart Fail 2011;13(4):416-22.
  196. Lynch BM, Cerin E, Owen N, Hawkes AL, Aitken JF. Television viewing time of colorectal cancer survivors is associated prospectively with quality of life. Cancer Causes Control 2011;2(8):1111-20.
  197. Lynch BM, Dunstan DW, Winkler E, Healy GN, Eakin E, Owen N. Objectively assessed physical activity, sedentary time and waist circumference among prostate cancer survivors: findings from the National Health and Nutrition Examination Survey (2003-2006). Eur J Cancer Care 2011;20(4):514-9.
  198. Lynch BM, Friedenreich CM, Winkler EA, Healy GN, Vallance JK, Eakin EG, Owen N. Associations of objectively assessed physical activity and sedentary time with biomarkers of breast cancer risk in postmenopausal women: findings from NHANES (2003-2006). Breast Cancer Res Treat 2011;130(1):183-94.
  199. Lyons JG, Stewart S. Prevention: convergent communicable and noncommunicable heart disease. Nat Rev Cardiol 2011;9(1):12-4. Review.
  200. Maeder MT, Gamboni SE, Kaye DM. Temporal changes in diastolic function in heart failure patients with restrictive filling. Int J Cardiol 2011;146(2):246-8.
  201. Maeder MT, Karapanagiotidis S, Dewar EM, Gamboni SE, Htun N, Kaye DM. Accuracy of Doppler echocardiography to estimate key hemodynamic variables in subjects with normal left ventricular ejection fraction. J Card Fail 2011;17(5):405-12.
  202. Maeder MT, Kaye DM. Transcardiac gradients of B-type natriuretic peptides are increased in human pulmonary arterial hypertension. Int J Cardiol 2011;151(1):117-9. Letter.
  203. Maeder MT, Khammy O, Dos Remedios C, Kaye DM. Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol 2011;58(5):474-80.
  204. Maeder MT, Staub D, Surnier Y, Reichlin T, Noveanu M, Breidthardt T, Potocki M, Schaub N, Conen D, Mueller C. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides. Int J Cardiol 2011;147(3):409-15.
  205. Mah LJ, Orlowski C, Ververis K, El-Osta A, Karagiannis TC. Utility of γH2AX as a molecular marker of DNA double-strand breaks in nuclear medicine: applications to radionuclide therapy employing auger electron-emitting isotopes. Curr Radiopharm 2011;4(1):59-67. Review.
  206. Mah LJ, Orlowski C, Ververis K, Vasireddy RS, El-Osta A, Karagiannis TC. Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaks. Genome Integr 2011;2(1):3. Review.
  207. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 2011;123(18):1940-6.
  208. Makanji Y, Walton KL, Chan KL, Gregorevic P, Robertson DM, Harrison CA. Generation of a specific activin antagonist by modification of the activin A propeptide. Endocrinology 2011;152(10):3758-68.
  209. Mancia G, Schumacher H, Redon J, Verdecchia P, Schmieder R, Jennings G, Yusoff K, Ryden L, Liu GL, Teo K, Sleight P, Yusuf S. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation 2011;124(16):1727-36.
  210. Mangat R, Su JW, Lambert JE, Clandinin MT, Wang Y, Uwiera RR, Forbes JM, Vine DF, Cooper ME, Mamo JC, Proctor SD. Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans. Diabet Med 2011;28(1):61-72.
  211. Maple-Brown LJ, Cunningham J, Hodge AM, Weeramanthri T, Dunbar T, Lawton PD, Zimmet PZ, Chadban SJ, Polkinghorne KR, Shaw JE, O'Dea K. High rates of albuminuria but not of low eGFR in urban indigenous Australians: the DRUID study. BMC Public Health 2011;11:346.
  212. Mariani JA, Smolic A, Preovolos A, Byrne MJ, Power JM, Kaye DM. Augmentation of left ventricular mechanics by recirculation-mediated AAV2/1-SERCA2a gene delivery in experimental heart failure. Eur J Heart Fail 2011;13(3):247-53.
  213. Marques FZ, Campain AE, Davern PJ, Yang YH, Head GA, Morris BJ. Genes influencing circadian differences in blood pressure in hypertensive mice. PLoS One 2011;6(4):e19203.
  214. Marques FZ, Campain AE, Davern PJ, Yang YH, Head GA, Morris BJ. Global identification of the genes and pathways differentially expressed in hypothalamus in early and established neurogenic hypertension. Physiol Genomics 2011;43(12):766-71.
  215. Masuo K. Hypertension and diabetes. Curr Hypertens Rev 2011;7(3):125. Editorial.
  216. Masuo K. Treatments for obesity-related hypertension. Curr Hypertens Rev 2011;7(3):184-99. Review.
  217. Masuo K, Lambert GW. Relationships of adrenoceptor polymorphisms with obesity. J Obes 2011;2011:609485. Review.
  218. Masuo K, Lambert GW. Epinephrine and its role in the development of obesity and hypertension. Curr Hypertens Rev 2011;7(3):144-52. Review.
  219. Masuo K, Rakugi H, Ogihara T, Esler MD, Lambert GW. Effects of weight loss on renal function in overweight Japanese men. Hypertens Res 2011;34(8):915-21.
  220. Masuo K, Tuck ML, Lambert GW. Hypertension and diabetes in obesity. Int J Hypertens 2011;2011:695869. Editorial.
  221. McLennan SN, Mathias JL, Brennan LC, Stewart S. Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. J Geriatr Psychiatry Neurol 2011;24(1):33-8.
  222. McNamara BJ, Sanson-Fisher R, D'Este C, Eades S. Type 2 diabetes in Indigenous populations: quality of intervention research over 20 years. Prev Med 2011;52(1):3-9. Review.
  223. Medi C, Kalman JM, Spence SJ, Teh AW, Lee G, Bader I, Kaye DM, Kistler PM. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol 2011;22(12):1317-24.
  224. Medi C, Sparks PB, Morton JB, Kistler PM, Halloran K, Rosso R, Vohra JK, Kumar S, Kalman JM. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J Cardiovasc Electrophysiol 2011;22(2):137-41.
  225. Meikle PJ, Christopher MJ. Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr Opin Lipidol 2011;22(3):210-5. Review.
  226. Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, MacIntosh GL, Goudey B, Stern L, Kowalczyk A, Haviv I, White AJ, Dart AM, Duffy SJ, Jennings GL, Kingwell BA. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 2011;31(11):2723-32.
  227. Mellor KM, Bell JR, Wendt IR, Davidoff AJ, Ritchie RH, Delbridge LM. Fructose modulates cardiomyocyte excitation-contraction coupling and Ca2+ handling in vitro. PLoS One 2011;6(9):e25204.
  228. Mellor KM, Bell JR, Young MJ, Ritchie RH, Delbridge LM. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Mol Cell Cardiol 2011;50(6):1035-43.
  229. Miao Y, Dobre D, Heerspink HJ, Brenner BM, Cooper ME, Parving HH, Shahinfar S, Grobbee D, de Zeeuw D. Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Diabetologia 2011;54(1):44-50.
  230. Miao Y, Ottenbros SA, Laverman GD, Brenner BM, Cooper ME, Parving HH, Grobbee DE, Shahinfar S, de Zeeuw D, Lambers Heerspink HJ. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial. Hypertension 2011;58(1):2-7.
  231. Michell DL, Andrews KL, Chin-Dusting JP. Endothelial dysfunction in hypertension: the role of arginase. Front Biosci (Schol Ed) 2011;3:946-60. Review.
  232. Michell DL, Andrews KL, Woollard KJ, Chin-Dusting JP. Imaging leukocyte adhesion to the vascular endothelium at high intraluminal pressure. J Vis Exp 2011;(54):pii:3221. Video.
  233. Minges KE, Cormick G, Unglik E, Dunstan DW. Evaluation of a resistance training program for adults with or at risk of developing diabetes: an effectiveness study in a community setting. Int J Behav Nutr Phys Act 2011;8:50.
  234. Minges KE, Zimmet P, Magliano DJ, Dunstan DW, Brown A, Shaw JE. Diabetes prevalence and determinants in Indigenous Australian populations: a systematic review. Diabetes Res Clin Pract 2011;93(2):139-49. Review.
  235. Mukhamedova N, D'Souza W, Low H, Kesani R, Chimini G, Sviridov D. Global functional knockdown of ATP binding cassette transporter A1 stimulates development of atherosclerosis in apoE K/O mice. Biochem Biophys Res Commun 2011;412(3):446-9.
  236. Murphy AJ, Woollard KJ, Suhartoyo A, Stirzaker RA, Shaw J, Sviridov D, Chin-Dusting JP. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein a-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol 2011;31(6):1333-41.
  237. Ng DC, Ng IH, Yeap YY, Badrian B, Tsoutsman T, McMullen JR, Semsarian C, Bogoyevitch MA. Opposing actions of extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) in regulating microtubule stabilization during cardiac hypertrophy. J Biol Chem 2011;286(2):1576-87.
  238. Nguyen TT, Shaw JE, Robinson C, Kawasaki R, Wang JJ, Kreis AJ, Wong TY. Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow. Diabetes Care 2011;34(6):1389-93.
  239. Nicholls HT, Kowalski G, Kennedy DJ, Risis S, Zaffino LA, Watson N, Kanellakis P, Watt MJ, Bobik A, Bonen A, Febbraio M, Lancaster GI, Febbraio MA. Hematopoietic cell-restricted deletion of CD36 reduces high-fat diet-induced macrophage infiltration and improves insulin signaling in adipose tissue. Diabetes 2011;60(4):1100-10.
  240. Nicol JL, Hoy WE, Su Q, Atkins RC, Polkinghorne KR. Reproducibility of urinary albumin assays by immunonephelometry after long-term storage at -70°C. Am J Kidney Dis 2011;58(4):685-7.
  241. Nikander R, Gagnon C, Dunstan DW, Magliano DJ, Ebeling PR, Lu ZX, Zimmet PZ, Shaw JE, Daly RM. Frequent walking, but not total physical activity, is associated with increased fracture incidence: a 5-year follow-up of an Australian population-based prospective study (AusDiab). J Bone Miner Res 2011;26(7):1638-47.
  242. Odom GL, Gregorevic P, Allen JM, Chamberlain JS. Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6. Mol Ther 2011;19(1):36-45.
  243. Orlowski C, Mah LJ, Vasireddy RS, El-Osta A, Karagiannis TC. Double-strand breaks and the concept of short- and long-term epigenetic memory. Chromosoma 2011;120(2):129-49. Review.
  244. Osei-Hwedieh DO, Amar M, Sviridov D, Remaley AT. Apolipoprotein mimetic peptides: mechanisms of action as anti-atherogenic agents. Pharmacol Ther 2011;130(1):83-91. Review.
  245. Osman N, Getachew R, Burch M, Lancaster G, Wang R, Wang H, Zheng W, Little PJ. TGF-β stimulates biglycan core protein synthesis but not glycosaminoglycan chain elongation via Akt phosphorylation in vascular smooth muscle. Growth Factors 2011;29(5):203-10.
  246. Ott C, Schneider MP, Delles C, Schlaich MP, Hilgers KF, Schmieder RE. Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men. Pharmacogenet Genomics 2011;21(6):347-9.
  247. Ott C, Schneider MP, Delles C, Schlaich MP, Schmieder RE. Reduction in basal nitric oxide activity causes albuminuria. Diabetes 2011;60(2):572-6.
  248. Owen N, Sugiyama T, Eakin EE, Gardiner PA, Tremblay MS, Sallis JF. Adults' sedentary behavior determinants and interventions. Am J Prev Med 2011;41(2):189-96. Review.
  249. Packham DK, Ivory SE, Reutens AT, Wolfe R, Rohde R, Lambers Heerspink H, Dwyer JP, Atkins RC, Lewis J. Proteinuria in Type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathy. Nephron Clin Pract 2011;118(4):c331-c338.
  250. Palma-Rigo K, Jackson KL, Davern PJ, Nguyen-Huu TP, Elghozi JL, Head GA. Renin-angiotensin and sympathetic nervous system contribution to high blood pressure in Schlager mice. J Hypertens 2011;29(11):2156-66.
  251. Pearce KL, Clifton PM, Noakes M. Egg consumption as part of an energy-restricted high-protein diet improves blood lipid and blood glucose profiles in individuals with Type 2 diabetes. Br J Nutr 2011;105(4):584-92.
  252. Peter K, Myles PS. Perioperative antiplatelet therapy: a knife-edged choice between thrombosis and bleeding still based on consensus rather than evidence. Thromb Haemost 2011;105(5):750-1. Comment.
  253. Pirola L, Balcerczyk A, Tothill RW, Haviv I, Kaspi A, Lunke S, Ziemann M, Karagiannis T, Tonna S, Kowalczyk A, Beresford-Smith B, Macintyre G, Kelong M, Hongyu Z, Zhu J, El-Osta A. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res 2011;21(10):1601-15.
  254. Ponsonby AL, Sun C, Ukoumunne OC, Pezic A, Venn A, Shaw JE, Dunstan DW, Barr EL, Blair SN, Cochrane J, Zimmet PZ, Dwyer T. Objectively measured physical activity and the subsequent risk of incident dysglycemia: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 2011;34(7):1497-502.
  255. Pretorius S, Stewart S, Sliwa K. Lessons from the Heart of Soweto Study and future directions. SA Heart 2011;8(2):104-13. Review.
  256. Rafehi H, El-Osta A, Karagiannis TC. Genetic and epigenetic events in diabetic wound healing. Int Wound J 2011;8(1):12-21. Review.
  257. Rafehi H, Orlowski C, Georgiadis GT, Ververis K, El-Osta A, Karagiannis TC. Clonogenic assay: adherent cells. J Vis Exp 2011;(49):pii:2573. Video.
  258. Reutens AT, Atkins RC. Epidemiology of diabetic nephropathy. Contrib Nephrol 2011;170:1-7. Review.
  259. Ribas V, Drew BG, Le JA, Soleymani T, Daraei P, Sitz D, Mohammad L, Henstridge DC, Febbraio MA, Hewitt SC, Korach KS, Bensinger SJ, Hevener AL. Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci USA 2011;108(39):16457-62.
  260. Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry 2011;45(6):458-65.
  261. Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases. Schizophr Res 2011;128(1-3):161-5.
  262. Rossi P, Francès Y, Kingwell BA, Ahimastos AA. Gender differences in artery wall biomechanical properties throughout life. J Hypertens 2011;29(6):1023-33. Review.
  263. Royce SG, Dang W, Ververis K, De Sampayo N, El-Osta A, Tang ML, Karagiannis TC. Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease. Epigenetics 2011;6(12):1463-70.
  264. Rumbold AR, Bailie RS, Si D, Dowden MC, Kennedy CM, Cox RJ, O'Donoghue L, Liddle HE, Kwedza RK, Thompson SC, Burke HP, Brown AD, Weeramanthri T, Connors CM. Delivery of maternal health care in Indigenous primary care services: baseline data for an ongoing quality improvement initiative. BMC Pregnancy Childbirth 2011;11:16.
  265. Salmon J, Arundell L, Hume C, Brown H, Hesketh K, Dunstan DW, Daly RM, Pearson N, Cerin E, Moodie M, Sheppard L, Ball K, Bagley S, Paw MC, Crawford D. A cluster-randomized controlled trial to reduce sedentary behavior and promote physical activity and health of 8-9 year olds: the Transform-Us! Study. BMC Public Health 2011;11:759.
  266. Samuel CS, Cendrawan S, Gao XM, Ming Z, Zhao C, Kiriazis H, Xu Q, Tregear GW, Bathgate RA, Du XJ. Relaxin remodels fibrotic healing following myocardial infarction. Lab Invest 2011;91(5):675-90.
  267. Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ. Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia 2011;54(9):2409-16.
  268. Sasongko MB, Wong TY, Nguyen TT, Kawasaki R, Jenkins A, Shaw J, Wang JJ. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care 2011;34(2):474-9.
  269. Schlaich M. Angiotensin receptor blockade in diabetic women of childbearing potential: an acceptable risk? Diabetologia 2011;54(6):1267-9. Comment.
  270. Schlaich MP. Sympathetic activation in chronic kidney disease: out of the shadow. Hypertension 2011;57(4):683-5. Comment.
  271. Schlaich MP, Krum H, Sobotka PA, Esler MD. Renal denervation and hypertension. Am J Hypertens 2011;24(6):635-42. Review.
  272. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Böhm M, Krum H, Lambert G, Esler MD, Sobotka PA. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens 2011;29(5):991-6.
  273. Schneider MP, Schlaich MP, Harazny JM, Raff U, Ritt M, Ott C, Schmieder RE. Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome. Obesity 2011;19(5):960-7.
  274. Shaw J. Diagnosis of prediabetes. Med Clin N Am 2011;95(2):341-52, viii. Review.
  275. Shaw JE. Intensive glucose lowering (HbA1c target<6.0%) for people with type 2 diabetes increases mortality. Evid Based Med 2011;16(6):186-7. Comment.
  276. Shaw JE, d'Emden MC, Goodall I. Is Australia ready to use glycated haemoglobin for the diagnosis of diabetes? Med J Aust 2011;195(1):7-8. Editorial.
  277. Si D, Dowden M, Kennedy C, Cox R, O'Donoghue L, Liddle H, Kwedza R, Connors C, Thompson S, Burke H, Brown A, Weeramanthri T, Shierhout G, Bailie R. Indigenous community care -- documented depression in patients with diabetes. Aust Fam Physician 2011;40(5):331-3.
  278. Siu J, Giskes K, Shaw J, Turrell G. Perceived weight status may contribute to education inequalities in five-year weight change among mid-aged women. Aust N Z J Public Health 2011;35(3):284-91.
  279. Skilton MR, Boussel L, Bonnet F, Bernard S, Douek PC, Moulin P, Serusclat A. Carotid intima-media and adventitial thickening: comparison of new and established ultrasound and magnetic resonance imaging techniques. Atherosclerosis 2011;215(2):405-10.
  280. Skilton MR, Chin-Dusting JP, Dart AM, Brazionis L, Lantieri O, O'Dea K, Balkau B; D.E.S.I.R. Study Group. Metabolic health, obesity and 9-year incidence of peripheral arterial disease: the D.E.S.I.R. study. Atherosclerosis 2011;216(2):471-6.
  281. Skilton MR, Lange C, Lantieri O, Balkau B, Bonnet F; DESIR study group. Number of children and change in markers of metabolic health over 9-years in men and women. Data from the DESIR study. Diabetes Metab 2011;37(4):351-5.
  282. Skilton MR, Maple-Brown LJ, Kapellas K, Celermajer DS, Bartold M, Brown A, O'Dea K, Slade GD, Jamieson LM. The effect of a periodontal intervention on cardiovascular risk markers in Indigenous Australians with periodontal disease: the PerioCardio study. BMC Public Health 2011;11:729.
  283. Sliwa K, Stewart S. A low-cost solar-powered blood-pressure device. Lancet 2011;378(9792):647-8. Comment.
  284. Sliwa K, Stewart S, Gersh BJ. Hypertension: a global perspective. Circulation 2011;123(24):2892-6. Review.
  285. Smith NJ, Chan HW, Qian H, Bourne AM, Hannan KM, Warner FJ, Ritchie RH, Pearson RB, Hannan RD, Thomas WG. Determination of the exact molecular requirements for type 1 angiotensin receptor epidermal growth factor receptor transactivation and cardiomyocyte hypertrophy. Hypertension 2011;57(5):973-80.
  286. Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Böhm M, Krum H. Sympatho-renal axis in chronic disease. Clin Res Cardiol 2011;100(12):1049-57. Review.
  287. Soldatos G, Jandeleit-Dahm K, Thomson H, Formosa M, D'orsa K, Calkin AC, Cooper ME, Ahimastos AA, Kingwell BA. Large artery biomechanics and diastolic dysfunctionin patients with type 2 diabetes. Diabet Med 2011;28(1):54-60.
  288. Soulimane S, Simon D, Shaw JE, Zimmet PZ, Vol S, Vistisen D, Magliano DJ, Borch-Johnsen K, Balkau B. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies. Diabet Med 2011;28(11):1311-8.
  289. Sozo F, Vela M, Stokes V, Kenna K, Meikle PJ, De Matteo R, Walker D, Brien J, Bocking A, Harding R. Effects of prenatal ethanol exposure on the lungs of postnatal lambs. Am J Physiol Lung Cell Mol Physiol 2011;300(1):L139-47.
  290. Stamatakis E, Hamer M, Dunstan DW. Screen-based entertainment time, all-cause mortality, and cardiovascular events population-based study with ongoing mortality and hospital events follow-up. J Am Coll Cardiol 2011;57(3):292-9.
  291. Stewart JE, Seimon RV, Otto B, Keast RS, Clifton PM, Feinle-Bisset C. Marked differences in gustatory and gastrointestinal sensitivity to oleic acid between lean and obese men. Am J Clin Nutr 2011;93(4):703-11.
  292. Stewart RA, Young AA, Anderson C, Teo KK, Jennings G, Cowan BR. Relationship between QRS duration and left ventricular mass and volume in patients at high cardiovascular risk. Heart 2011;97(21):1766-70.
  293. Stewart S. Tackling heart disease at the global level: implications of the United Nations' statement on the prevention and control of noncommunicable disease. Circ Cardiovasc Qual Outcomes 2011;4(6):667-9. Comment.
  294. Stewart S, Carrington M, Pretorius S, Methusi P, Sliwa K. Standing at the crossroads between new and historically prevalent heart disease: effects of migration and socio-economic factors in the Heart of Soweto cohort study. Eur Heart J 2011;32(4):492-9.
  295. Stewart S, Carrington M, Sliwa K. Barriers and challenges for primary and secondary prevention of heart disease in sub-Saharan Africa. SA Heart 2011;8(2):96-102. Review.
  296. Stewart S, Carrington MJ, Marwick T, Davidson PM, Macdonald P, Horowitz J, Krum H, Newton PJ, Reid C, Scuffham PA; Which Heart failure Intervention is most Cost-effective & consumer friendly in reducing Hospital care trial Investigators. The WHICH? trial: rationale and design of a pragmatic randomized, multicentre comparison of home- vs. clinic-based management of chronic heart failure patients. Eur J Heart Fail 2011;13(8):909-16.
  297. Stewart S, Carrington MJ, Swemmer C, Kurstjens N, Jennings GL. Optimising management of hypertension in primary care: the Valsartan Intensified Primary Care Reduction of Blood Pressure (Viper-Bp) Study. Int J Cardiol 2011;153(3):317-22.
  298. Stewart S, Libhaber E, Carrington M, Damasceno A, Abbasi H, Hansen C, Wilkinson D, Sliwa K. The clinical consequences and challenges of hypertension in urban-dwelling black Africans: insights from the Heart of Soweto Study. Int J Cardiol 2011;146(1):22-7.
  299. Stewart S, Mocumbi AO, Carrington MJ, Pretorius S, Burton R, Sliwa K. A not-so-rare form of heart failure in urban black Africans: pathways to right heart failure in the Heart of Soweto Study cohort. Eur J Heart Fail 2011;13(10):1070-7.
  300. Straub A, Krajewski S, Hohmann JD, Westein E, Jia F, Bassler N, Selan C, Kurz J, Wendel HP, Dezfouli S, Yuan Y, Nandurkar H, Jackson S, Hickey MJ, Peter K. Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target. Arterioscler Thromb Vasc Biol 2011;31(7):1607-16.
  301. Straznicky NE, Grima MT, Eikelis N, Nestel PJ, Dawood T, Schlaich MP, Chopra R, Masuo K, Esler MD, Sari CI, Lambert GW, Lambert EA. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. J Clin Endocrinol Metab 2011;96(3):E503-8.
  302. Straznicky NE, Grima MT, Lambert EA, Eikelis N, Dawood T, Lambert GW, Nestel PJ, Masuo K, Sari CI, Chopra R, Mariani JA, Schlaich MP. Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals. J Hypertens 2011;29(3):553-64.
  303. Stub D, Bernard S, Duffy SJ, Kaye DM. Post cardiac arrest syndrome: a review of therapeutic strategies. Circulation 2011;123(13):1428-35. Review.
  304. Stub D, Hengel C, Chan W, Jackson D, Sanders K, Dart AM, Hilton A, Pellegrino V, Shaw JA, Duffy SJ, Bernard S, Kaye DM. Usefulness of cooling and coronary catheterization to improve survival in out-of-hospital cardiac arrest. Am J Cardiol 2011;107(4):522-7.
  305. Stub D, Smith K, Bray JE, Bernard S, Duffy SJ, Kaye DM. Hospital characteristics are associated with patient outcomes following out-of-hospital cardiac arrest. Heart 2011;97(18):1489-94.
  306. Sverdlov AL, Ngo DT, Nightingale AK, Rajendran S, Mishra K, Heresztyn T, Ritchie RH, Marwick TH, Frenneaux MP, Horowitz JD. The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload. Nitric Oxide 2011;25(1):41-6.
  307. Sviridov D. Fenofibrate, homocysteine, cholesterol efflux and primum non nocere. Atherosclerosis 2011;219(1):24-5. Comment.
  308. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011;57(5):911-7.
  309. Syreeni A, El-Osta A, Forsblom C, Sandholm N, Parkkonen M, Tarnow L, Parving HH, McKnight AJ, Maxwell AP, Cooper ME, Groop PH; FinnDiane Study Group. Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes. Diabetes 2011;60(11):3073-80.
  310. Ta HT, Prabhu S, Leitner E, Jia F, von Elverfeldt D, Jackson K, Heidt T, Nair A, Pearce H, von Zur Muhlen C, Wang X, Peter K, Hagemeyer CE. Enzymatic single-chain antibody tagging: a universal approach to targeted molecular imaging and cell homing in cardiovascular disease. Circ Res 2011;109(4):365-73.
  311. Tan HC, Tai ES, Sviridov D, Nestel PJ, Ng C, Chan E, Teo Y, Wai DC. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus. J Clin Lipidol 2011;5(6):467-73.
  312. Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wng JL, Norman RJ, Costello MF; Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011;195(6):S65-112. Guidelines.
  313. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence S, Morton JB, Sanders P, Kalman JM. Electroanatomic properties of the pulmonary veins: slowed conduction, low voltage and altered refractoriness in AF patients. J Cardiovasc Electrophysiol 2011;22(10):1083-91.
  314. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, Sparks PB, Morton JB, Sanders P, Kalman JM. The relationship between complex fractionated electrograms and atrial low-voltage zones during atrial fibrillation and paced rhythm. Europace 2011;13(12):1709-16.
  315. Teh AW, Medi C, Lee G, Rosso R, Sparks PB, Morton JB, Kistler PM, Halloran K, Vohra JK, Kalman JM. Long-term outcome following ablation of atrial flutter occurring late after atrial septal defect repair. Pacing Clin Electrophysiol 2011;34(4):431-5.
  316. Thomas M. Bardoxolone: augmenting the Yin in chronic kidney disease. Diab Vasc Dis Res 2011;8(4):303-4. Editorial.
  317. Thomas MC. Pathogenesis and progression of proteinuria. Contrib Nephrol 2011;170:48-56. Review.
  318. Thomas MC. Advanced glycation end products. Contrib Nephrol 2011;170:66-74. Review.
  319. Thomas MC, Cooper ME. Diabetes: bardoxolone improves kidney function in type 2 diabetes. Nat Rev Nephrol 2011;7(10):552-3. Review.
  320. Thomas MC, Groop PH. New approaches to the treatment of nephropathy in diabetes. Expert Opin Investig Drugs 2011;20(8):1057-71. Review.
  321. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolonen N, Saraheimo M, Gordin D, Groop PH; FinnDiane Study Group. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011;34(4):861-6.
  322. Thomas MC, Söderlund J, Lehto M, Mäkinen VP, Moran JL, Cooper ME, Forsblom C, Groop PH; FinnDiane Study Group. Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia 2011;54(10):2669-77.
  323. Thorp AA, Owen N, Neuhaus M, Dunstan DW. Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996-2011. Am J Prev Med 2011;41(2):207-15. Review.
  324. Thrift AG, Cadilhac DA, Eades S. Excess risk of stroke in Australia's Aboriginal and Torres Strait Islander populations. Stroke 2011;42(6):1501-2. Comment.
  325. Thrift AG, Evans RG, Kalyanram K, Kartik K, Fitzgerald SM, Srikanth V. Gender-specific effects of caste and salt on hypertension in poverty: a population-based study. J Hypertens 2011;29(3):443-50.
  326. Tikellis C, Bernardi S, Burns WC. Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Curr Opin Nephrol Hypertens 2011;20(1):62-8. Review.
  327. Toffoli B, Pickering RJ, Tsorotes D, Wang B, Bernardi S, Kantharidis P, Fabris B, Zauli G, Secchiero P, Thomas MC. Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop. Atherosclerosis 2011;218(1):61-8.
  328. Topcic D, Kim W, Holien JK, Jia F, Armstrong PC, Hohmann JD, Straub A, Krippner G, Haller CA, Domeij H, Hagemeyer CE, Parker MW, Chaikof EL, Peter K. An activation-specific platelet inhibitor that can be turned on/off by medically used hypothermia. Arterioscler Thromb Vasc Biol 2011;31(9):2015-23.
  329. Troughton RW, Ritzema J, Eigler NL, Melton IC, Krum H, Adamson PB, Kar S, Shah PK, Whiting JS, Heywood JT, Rosero S, Singh JP, Saxon L, Matthews R, Crozier IG, Abraham WT, Kaye DM; HOMEOSTASIS Investigators. Direct left atrial pressure monitoring in severe heart failure: long-term sensor performance. J Cardiovasc Transl Res 2011;4(1):3-13.
  330. Tu Y, Wu T, Dai A, Pham Y, Chew P, de Haan JB, Wang Y, Toh BH, Zhu H, Cao Z, Cooper ME, Chai Z. Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-β in diabetic nephropathy. Kidney Int 2011;79(2):199-209.
  331. Ukena C, Mahfoud F, Kindermann I, Barth C, Lenski M, Kindermann M, Brandt MC, Hoppe UC, Krum H, Esler M, Sobotka PA, Böhm M. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol 2011;58(11):1176-82.
  332. Urquhart DM, Berry P, Wluka AE, Strauss BJ, Wang Y, Proietto J, Jones G, Dixon JB, Cicuttini FM. 2011 Young Investigator Award winner: Increased fat mass is associated with high levels of low back pain intensity and disability. Spine 2011;36(16):1320-5.
  333. Urquhart DM, Tobing JF, Hanna FS, Berry P, Wluka AE, Ding C, Cicuttini FM. What is the effect of physical activity on the knee joint? A systematic review. Med Sci Sports Exerc 2011;43(3):432-42. Review.
  334. Vaddadi G, Guo L, Esler M, Socratous F, Schlaich M, Chopra R, Eikelis N, Lambert G, Trauer T, Lambert E. Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythmia Electrophysiol 2011;4(5):711-8.
  335. Vallance JK, Winkler EA, Gardiner PA, Healy GN, Lynch BM, Owen N. Associations of objectively-assessed physical activity and sedentary time with depression: NHANES (2005-2006). Prev Med 2011;53(4-5):284-8.
  336. van den Hurk K, Magliano DJ, Alssema M, Schlaich MP, Atkins RC, Reutens AT, Nijpels G, Dekker JM, Shaw JE. Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: the AusDiab study. J Hypertens 2011;29(5):953-60.
  337. Van Dyck D, Cardon G, Deforche B, Giles-Corti B, Sallis JF, Owen N, De Bourdeaudhuij I. Environmental and psychosocial correlates of accelerometer-assessed and self-reported physical activity in Belgian adults. Int J Behav Med 2011;18(3):235-45.
  338. Van Dyck D, Cardon G, Deforche B, Owen N, De Bourdeaudhuij I. Relationships between neighborhood walkability and adults' physical activity: How important is residential self-selection? Health Place 2011;17(4):1011-4.
  339. Van Dyck D, Cardon G, Deforche B, Owen N, De Cocker K, Wijndaele K, De Bourdeaudhuij I. Socio-demographic, psychosocial and home-environmental attributes associated with adults' domestic screen time. BMC Public Health 2011;11:668.
  340. Van Dyck D, De Greef K, Deforche B, Ruige J, Tudor-Locke CE, Kaufman JM, Owen N, De Bourdeaudhuij I. Mediators of physical activity change in a behavioral modification program for type 2 diabetes patients. Int J Behav Nutr Phys Act 2011;8:105.
  341. Ververis K, Karagiannis TC. Potential non-oncological applications of histone deacetylase inhibitors. Am J Transl Res 2011;3(5):454-67. Review.
  342. Ververis K, Rodd AL, Tang MM, El-Osta A, Karagiannis TC. Histone deacetylase inhibitors augment doxorubicin-induced DNA damage in cardiomyocytes. Cell Mol Life Sci 2011;68(24):4101-14.
  343. Waardenberg AJ, Bernardo BC, Ng DC, Shepherd PR, Cemerlang N, Sbroggiò M, Wells CA, Dalrymple BP, Brancaccio M, Lin RC, McMullen JR. Phosphoinositide 3-kinase (PI3K(p110alpha)) directly regulates key components of the Z-disc and cardiac structure. J Biol Chem 2011;286(35):30837-46.
  344. Walls HL, Magliano DJ, McNeil JJ, Stevenson C, Ademi Z, Shaw J, Peeters A. Predictors of increasing waist circumference in an Australian population. Public Health Nutr 2011;14(5):870-81.
  345. Wang B, Koh P, Winbanks C, Coughlan MT, McClelland A, Watson A, Jandeleit-Dahm K, Burns WC, Thomas MC, Cooper ME, Kantharidis P. miR-200a prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes 2011;60(1):280-7.
  346. Wang Y, Simpson JA, Wluka AE, Teichtahl AJ, English DR, Giles GG, Graves S, Cicuttini FM. Is physical activity a risk factor for primary knee or hip replacement due to osteoarthritis? A prospective cohort study. J Rheumatol 2011;38(2):350-7.
  347. Waters LA, Galichet B, Owen N, Eakin E. Who participates in physical activity intervention trials? J Phys Act Health 2011;8(1):85-103.
  348. Watson AM, Soro-Paavonen A, Sheehy K, Li J, Calkin AC, Koitka A, Rajan SN, Brasacchio D, Allen TJ, Cooper ME, Thomas MC, Jandeleit-Dahm KJ. Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice. Diabetologia 2011;54(3):681-9.
  349. Watts GF, Sullivan DR, Poplawski N, van Bockxmeer F, Hamilton-Craig I, Clifton PM, O'Brien R, Bishop W, George P, Barter PJ, Bates T, Burnett JR, Coakley J, Davidson P, Emery J, Martin A, Farid W, Freeman L, Geelhoed E, Juniper A, Kidd A, Kostner K, Krass I, Livingston M, Maxwell S, O'Leary P, Owaimrin A, Redgrave TG, Reid N, Southwell L, Suthers G, Tonkin A, Towler S, Trent R; Familial Hypercholesterolaemia Australasia Network Consensus Group (Australian Atherosclerosis Society). Familial hypercholesterolaemia: a model of care for Australasia. Atheroscler Suppl 2011;12(2):221-63.
  350. Weeks KL, McMullen JR. The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes? Physiology 2011;26(2):97-105. Review.
  351. 351. White SL, Dunstan DW, Polkinghorne KR, Atkins RC, Cass A, Chadban SJ. Physical inactivity and chronic kidney disease in Australian adults: the AusDiab study. Nutr Metab Cardiovasc Dis 2011;21(2):104-12.
  352. 352. White SL, Yu R, Craig JC, Polkinghorne KR, Atkins RC, Chadban SJ. Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis 2011;58(1):19-28.
  353. 353. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94(3):311-21.
  354. 354. Williams AD, Anderson MJ, Selig S, Carey MF, Febbraio MA, Hayes A, Toia D, Harrap SB, Hare DL. Differential response to resistance training in CHF according to ACE genotype. Int J Cardiol 2011;149(33):330-4.
  355. 355. Wilson WM, Andrianopoulos N, Clark D, Duffy SJ, Brennan A, Harries I, New G, Sebastian M, Loane P, Reid C, Ajani AE. Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents. Am J Cardiol 2011;108(7):936-42.
  356. Winbanks CE, Darby IA, Kelynack KJ, Pouniotis D, Becker GJ, Hewitson TD. Explanting is an ex vivo model of renal epithelial-mesenchymal transition. J Biomed Biotechnol 2011;212819.
  357. Winbanks CE, Wang B, Beyer C, Koh P, White L, Kantharidis P, Gregorevic P. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem 2011;286(16):13805-14.
  358. Wolf D, Hohmann JD, Wiedemann A, Bledzka K, Blankenbach H, Marchini T, Gutte K, Zeschky K, Bassler N, Hoppe N, Rodriguez AO, Herr N, Hilgendorf I, Stachon P, Willecke F, Duerschmied D, von zur Muhlen C, Soloviev DA, Zhang L, Bode C, Plow EF, Libby P, Peter K, Zirlik A. Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice. Circ Res 2011;109(11):1269-79.
  359. Xu Q, Dalic A, Fang L, Kiriazis H, Ritchie R, Sim K, Gao XM, Drummond G, Sarwar M, Zhang YY, Dart A, Du XJ. Myocardial oxidative stress contributes to transgenic β(2) -adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol 2011;162(5):1012-28.
  360. Xu TB, Eppel GA, Head GA, Evans RG. Angiotensin II type 1 receptors and systemic hemodynamic and renal responses to stress and altered blood volume in conscious rabbits. Front Physiol 2011;2:40.
  361. Xu Y, Schnorrer P, Proietto A, Kowalski G, Febbraio MA, Acha-Orbea H, Dickins RA, Villadangos JA. IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression. J Immunol 2011;186(6):3666-73.
  362. Yan BP, Ajani AE, Clark DJ, Duffy SJ, Andrianopoulos N, Brennan AL, Loane P, Reid CM. Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne Interventional Group registry. Med J Aust 2011;195(3):122-7.
  363. Yang KC, Jay PY, McMullen JR, Nerbonne JM. Enhanced cardiac PI3Kα signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure. Cardiovasc Res 2011;93(2):252-62.
  364. Ziemann M, Bhave M, Zachgo S. Bioinformatic studies of the wheat glutaredoxin gene family and functional analysis of the ROXY1 orthologues. Funct Plant Biol 2011;38(1):25-34.
  365. Zimmet P, Alberti KG, Rubino F, Dixon JB. IDF's view of bariatric surgery in type 2 diabetes. Lancet 2011;378(9786):108-10. Comment.
  366. Zomer E, Owen A, Magliano DJ, Liew D, Reid C. Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the 'old' versus the 'new' Framingham equation. Eur J Cardiovasc Prev Rehabil 2011;18(1):115-20.

Book chapters

  1. Abbott AL. Why asymptomatic carotid stenosis is now a medical condition. In: Davies AH (ed), Fast Facts: Vascular and Endovascular Surgery Highlights 2010-2011, Health Press, UK. 2011. Chapter 2.
  2. Abbott AL. Transcranial doppler and cerebrovascular risk stratification in patients with internal carotid artery atherosclerosis. In: Nicolaides A, Beach KW, Kyriacou E, Pattichis CS (eds), Ultrasound and Carotid Bifurcation Atherosclerosis, Springer, New York, USA. 2011. pp571-93.
  3. de Haan JB, Jandeleit-Dahm KA, Allen TJ. Role of oxidative stress and targeted antioxidant therapies in experimental models of diabetic complications. In: Basu S, Wiklund L (eds), Studies on Experimental Models, Oxidative Stress in Applied Basic Research and Clinical Practice series, Springer-Humana Press. 2011. pp3-38.
  4. Eikelis N, Lambert G. The brain and leptin resistance and implications for food-related disorders. In: Preedy V, Watson RR, Martin CR (eds), Handbook of Behavior, Food and Nutrition, Springer, New York, USA. 2011. pp1301-15.
  5. Forbes JM, Coughlan MT, Cooper ME. Role of oxidative stress in diabetic nephropathy. In: Prabhakar SS (ed), Advances in the Pathogenesis of Diabetic Nephropathy, Nova Publishers, New York, USA. 2011. Chapter 9.
  6. Masuo K, Lambert GW. Treatments for hypertension in Type 2 diabetes-non-pharmacological and pharmacological measurements. In: Zimering M (ed), Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications, InTech, USA. 2011. Chapter 13, pp233-62.
  7. Masuo K, Lambert GW, Esler MD. Epinephrine and its role in the development of obesity, hypertension and obesity-related hypertension. In: Berhardt L (ed), Advances in Medicine and Biology, Volume 17, Nova Publishers, New York, USA. 2011. pp61-77.
  8. McDonald D, McDonald K, Lambert G. DEXA-Dan: Embedding the corporeal body. In: Fischer G, Vassen F (eds), Collective Creativity: Collaborative Work in the Sciences, Literature and the Arts, Rodopi, Amsterdam, The Netherlands. 2011. pp143-57.
  9. Nestel P. Managing hyperlipidaemia: criteria for investigating lipids. In: Kellerman G (ed), Abnormal Laboratory Results, 3rd edition, McGraw Hill, Sydney, Australia 2011. Chapter 18.
  10. Nestel P. Drugs that affect lipid metabolism. In: Aronson JK (ed), Side Effects of Drugs, Annual 33rd edition, Elsevier BV 2011. Chapter 44. pp921-34.
  11. Prabhu S, Sharma R, Peter K. Platelets in the pathogenesis of vascular disease and their role as a therapeutic target. In: Fitridge R, Thompson M (eds), Mechanisms of Vascular Disease: A reference book for vascular specialists, Barr Smith Press, Adelaide 2011. Chapter 11.
  12. Prior LJ, Head GA, Armitage JA. Experimental models of maternal wbesity and high-fat diet during pregnancy and programmed obesity in the offspring. In: Lustig RH (ed), Obsesity Before Birth: Maternal and Paternal Influences on the Offspring, Springer NY 2011. Chapter 12. pp241-260.
  13. Stewart S. Heart Failure: Disease Management Programs. In: Tse H-F, Lip G, Coats AJS (eds), Oxford Desk Reference: Cardiology, Oxford University Press 2011. Chapter 6.4. pp226-8.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more